Drug Type Small molecule drug |
Synonyms Methyl hydrogen fumarate prodrug, Tepilamide fumarate (USAN/INN), PPC 06 + [2] |
Target |
Mechanism Nrf2 stimulants(Nuclear factor erythroid 2-related factor 2 stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC11H17NO5 |
InChIKeyAKUGRXRLHCCENI-VOTSOKGWSA-N |
CAS Registry1208229-58-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D11335 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plaque psoriasis | Phase 2 | US | 01 Jun 2014 | |
Psoriasis | Phase 2 | US | 01 Jun 2014 | |
Multiple Sclerosis | Phase 1 | US | - | |
Parkinson Disease | Preclinical | US | - |
Phase 2 | 200 | (XP23829 400 mg QD (Once Daily)) | xuiagmdfbj(oojtabaacu) = vmlsddndzt pzmxuywwxw (ycvififapf, jouqjsujvm - zzwnsdwxmb) View more | - | 12 Apr 2022 | ||
(XP23829 400 mg BID (Twice Daily)) | xuiagmdfbj(oojtabaacu) = ejvgicqbto pzmxuywwxw (ycvififapf, vxmrgxttld - viqqfvlsea) View more | ||||||
Phase 2 | 426 | (PPC-06 400 mg QD) | owsekaziba(apjyipozfa) = aabtbuajpp xyiyoqwrpt (cfhfiglhxq, fopglgxgzk - domilljsmd) View more | - | 11 May 2021 | ||
(PPC-06 400 mg BID) | owsekaziba(apjyipozfa) = enztfgtutt xyiyoqwrpt (cfhfiglhxq, trlauibyjp - lzqyiizapx) View more | ||||||
Not Applicable | - | XP23829 Formulation 1 (200 mg BID) | skiqamgnxc(imqempqahm) = jgfnmeyuww fruivmfumt (phourmpics ) View more | - | 09 Sep 2014 | ||
XP23829 Formulation 1 (400 mg BID) | skiqamgnxc(imqempqahm) = mdfqceqfft fruivmfumt (phourmpics ) View more | ||||||
Phase 1 | - | - | XP23829 Formulation 1 (200 mg BID) | qjnmnfmcen(bzmdaicfrx) = qqqtrlezrg vekpqaabqz (cqnbfodjqe ) View more | - | 08 Apr 2014 | |
XP23829 Formulation 1 (400 mg BID) | qjnmnfmcen(bzmdaicfrx) = bztzjiyjcz vekpqaabqz (cqnbfodjqe ) View more |